期刊文献+

35例胸膜间皮瘤临床分析 被引量:2

Clinical analysis of 35 cases of malignant pleural mesothelioma
下载PDF
导出
摘要 目的探讨胸膜恶性间皮瘤的临床特点与治疗经验。方法回顾性分析中国医科大学附属第一医院1998年6月~2015年10月收治的35例胸膜恶性间皮瘤患者的临床资料。结果全部35例患者中,15例术前曾存在不同程度的误诊,误诊率为42.8%,1年生存率为60%,3年生存率为5.7%。大多数患者在术后3个月~1年复发,1年复发率为71.4%。结论胸膜恶性间皮瘤发病率低、恶性程度高、预后差,应根据患者疾病分期、病理分型、心肺功能等因素综合考虑,制订个体化治疗策略。 Objective To explore the clinical characteristics and treatment experience of malignant pleural mesothelioma. Methods The data of 35 cases of MPM were analyzed retrospectively in the First Hospital of China Medical University from June 1998 to October 2015. Results In all the patients, 15 cases was misdiagnosised, and the misdianosis rate was 42.8%. The 1-year-survival rate was 60% and the 3-year-survival rate was 5.7%. Most of the patients was recurrence during 3 months to 1 year after surgery, and the 1-year-recurrence rate was 71.4%. Conclusion MPM has low incidence, high grade malignance and bad prognosis. It should work out individualized treatment strategies considering the staging of disease, pathological type and cardiopulmonary function of each patient.
出处 《中国医药导报》 CAS 2016年第10期44-46,共3页 China Medical Herald
基金 辽宁省自然科学基金项目(2015020561) 中国医科大学附属第一医院科学研究基金项目(fsfh1514)
关键词 恶性间皮瘤 诊断 治疗 malignant pleural mesothelioma Dianosis Treatment
  • 相关文献

参考文献3

二级参考文献119

  • 1陈新,何明,刘庆熠,杨立伟,孟宪利.局限性胸膜间皮瘤的诊断和外科治疗[J].中国肿瘤临床,2004,31(12):679-681. 被引量:3
  • 2马晨光,甘北南,张晓华.恶性胸膜间皮瘤的诊断与治疗[J].黑龙江医学,2007,31(2):95-97. 被引量:7
  • 3Bottomley A, Coens C, Efficace F, et al. Symptoms and patientreported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTCNCIC08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.J Clin Oncol,2007; 25: 5770-5776.
  • 4Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.Chest 1995; 107: 1454-1456.
  • 5Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma:results of surgery. EurJ Cardiothorac Surg 1997; 11: 210-213.
  • 6Halstead JC, Lim E, Venkateswaran RM, et al. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005; 31: 314-320.
  • 7Nakas A, Martin Ucar AE, Edwards JG, et al. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83-88.
  • 8Martin-Ucar AE, Edwards JG, Rengajaran A, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. EurJ Cardiothorac Surg 2001; 20:1117-1121.
  • 9Dogan AUp Baris YI, Dogan M, et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006; 66: 5063-5068.
  • 10Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 2007; 369: 844-849.

共引文献75

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部